StockData
Elicio Therapeutics, Inc. logo

Elicio Therapeutics, Inc. (ELTX) stock

ELTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$1.43−0.05 (-3.38%)

Close on Nov 17, 2026Market cap $37.58MP/E –Yield –

Elicio Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Elicio Therapeutics's price to book ratio was 4.5× on Nov 11, 2026, against 93.4× a year earlier. Over the last 3 years it ranged from 0.1× to 141.3×, with a median of 5.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.5×−31.5
2025Dec 31, 202536.0×+25.1
2024Jul 31, 202410.9×+5.6
2023Dec 29, 20235.3×+5.1
2022Jan 31, 20220.1×−0.0
2021Dec 31, 20210.1×–

More Elicio Therapeutics figures

See a number that looks wrong?